|Master Investor Magazine
Never miss an issue of Master Investor Magazine – sign-up now for free!
FTSE 250 precision instruments manufacturer Spectris (LON:SXS) saw its share price rise by 2.17% to 2,546p (as of 14:20 BST) as like-for-like sales rose by 3% over the four months to 30th April despite moderation in certain key markets. Management said that this was largely driven by the in-line instrumentation and materials analysis arms, while concept life sciences and tests & measurement struggled.
Overall performance is in line with expectations and the company said that it was focusing on improving margins to combat the effects of macro-economic worries.